1 terminated, 1 withdrawn. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Terminated 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Stage IVB Nasopharyngeal Carcinoma: new trials by email Literature Review of Stage IVB Nasopharyngeal Carcinoma trials Research Report on Stage IVB Nasopharyngeal Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Durvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive Nasopharyngeal Cancer Durvalumab, Epacadostat - Epstein-Barr Virus Positive, Metastatic Nasopharyngeal Carcinoma | Phase 2 | Withdrawn | Alain Algazi | 2020-12-01 | 2020-10-26 | |
| Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer Physiologic Testing, Quality-of-Life Assessment, Sham Intervention - Stage 0 Nasopharyngeal Carcinoma, Stage 0 Paranasal Sinus Cancer | Not applicable | Terminated | Stanford University | 15 | 2016-12-01 | 2019-02-05 |
Nasopharyngeal Carcinoma (2) · Paranasal Sinus Neoplasms (1)
Carcinoma (2) · Head and Neck Neoplasms (2) · Nasopharyngeal Diseases (2) · Nasopharyngeal Neoplasms (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Otorhinolaryngologic Diseases (2) · Otorhinolaryngologic Neoplasms (2) · Pharyngeal Diseases (2) · Pharyngeal Neoplasms (2) · Stomatognathic Diseases (2) · Nose Diseases (1) · Nose Neoplasms (1)
Coal Tar (1) · Disulfides (1) · Eucalyptus Oil (1) · Immunoglobulin G (1) · Therapeutics (1) · durvalumab (1) · epacadostat (1)
Alain Algazi (1) · Stanford University (1)
United States (1)
Alain P Algazi, MD (1) · Zara Patel (1)